Chrysin overcomes TRAIL resistance of cancer cells through Mcl-1 downregulation by inhibiting STAT3 phosphorylation

International Journal of Oncology

Volumn 43, Issue 1, 2013, Pages 329-337

  Lirdprapamongkol, Kriengsak ^a   Sakurai, Hiroaki ^c,d   Abdelhamed, Sherif ^c   Yokoyama, Satoru ^c   Athikomkulchai, Sirivan ^f   Viriyaroj, Amornrat ^f   Awale, Suresh ^e   Ruchirawat, Somsak ^b,g,h   Svasti, Jisnuson ^a   Saiki, Ikuo ^c  

^a Krung Thep Maha Nakhon   (Thailand)

^b Toxicology and Management of Chemicals   (Thailand)

^c UNIVERSITY OF TOYAMA   (Japan)

^d GRADUATE SCHOOL OF MEDICINE   (Japan)

^e UNIVERSITY OF TOYAMA   (Japan)

^f SRINAKHARINWIROT UNIVERSITY   (Thailand)

^g Research and Innovation   (Thailand)

^h THAILAND CENTER OF EXCELLENCE IN PHYSICS   (Thailand)

Author keywords

[No Author keywords available]

Indexed keywords

CHRYSIN; CUCURBITACIN; GLUTATHIONE; PROPOLIS; PROTEIN MCL 1; STAT3 PROTEIN; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ANALYSIS; ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER CELL CULTURE; CANCER RESISTANCE; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVATION; ENZYME INHIBITION; FEMALE; GENE EXPRESSION; HELA CELL; HONEYBEE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SENSITIZATION; SIGNAL TRANSDUCTION; UTERINE CERVIX CANCER;

FEMALE; FLAVONOIDS; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUTATHIONE; HELA CELLS; HUMANS; LUNG NEOPLASMS; MYELOID CELL LEUKEMIA SEQUENCE 1 PROTEIN; NF-KAPPA B; PHOSPHORYLATION; PROPOLIS; STAT3 TRANSCRIPTION FACTOR; TNF-RELATED APOPTOSIS-INDUCING LIGAND; UTERINE CERVICAL NEOPLASMS;

EID: 84879460546     PISSN: 10196439     EISSN: 17912423     Source Type: Journal    
DOI: 10.3892/ijo.2013.1926     Document Type: Article

References (44)

1. Kruyt FA: TRAIL and cancer therapy. Cancer Lett 263: 14-25, 2008.
2. Wang S: The promise of cancer therapeutics targeting the TNF-related apoptosis-inducing ligand and TRAIL receptor pathway. Oncogene 27: 6207-6215, 2008.
3. Hellwig CT and Rehm M: TRAIL signaling and synergy mechanisms used in TRAIL-based combination therapies. Mol Cancer Ther 11: 3-13, 2012.
4. Mahalingam D, Szegezdi E, Keane M, de Jong S and Samali A: TRAIL receptor signalling and modulation: are we on the right TRAIL? Cancer Treat Rev 35: 280-288, 2009.
5. Ishibashi M and Ohtsuki T: Studies on search for bioactive natural products targeting TRAIL signaling leading to tumor cell apoptosis. Med Res Rev 28: 688-714, 2008.
6. Bankova V: Recent trends and important developments in propolis research. Evid Based Complement Alternat Med 2: 29-32, 2005.
7. Szliszka E, Czuba ZP, Domino M, Mazur B, Zydowicz G and Krol W: Ethanolic extract of propolis (EEP) enhances the apoptosis-inducing potential of TRAIL in cancer cells. Molecules 14: 738-754, 2009.
8. Awale S, Shrestha SP, Tezuka Y, Ueda JY, Matsushige K and Kadota S: Neoflavonoids and related constituents from Nepalese propolis and their nitric oxide production inhibitory activity. J Nat Prod 68: 858-864, 2005. (Pubitemid 41017498)
9. Awale S, Li F, Onozuka H, Esumi H, Tezuka Y and Kadota S: Constituents of Brazilian red propolis and their preferential cytotoxic activity against human pancreatic PANC-1 cancer cell line in nutrient-deprived condition. Bioorg Med Chem 16: 181-189, 2008.
10. Hernandez J, Goycoolea FM, Quintero J, et al: Sonoran propolis: chemical composition and antiproliferative activity on cancer cell lines. Planta Med 73: 1469-1474, 2007. (Pubitemid 350240504)
11. Woo KJ, Jeong YJ, Park JW and Kwon TK: Chrysin-induced apoptosis is mediated through caspase activation and Akt inactivation in U937 leukemia cells. Biochem Biophys Res Commun 325: 1215-1222, 2004. (Pubitemid 39535892)
12. Weng MS, Ho YS and Lin JK: Chrysin induces G1 phase cell cycle arrest in C6 glioma cells through inducing p21Waf1/Cip1 expression: involvement of p38 mitogen-activated protein kinase. Biochem Pharmacol 69: 1815-1827, 2005.
13. Kachadourian R, Leitner HM and Day BJ: Selected flavonoids potentiate the toxicity of cisplatin in human lung adenocarcinoma cells: a role for glutathione depletion. Int J Oncol 31: 161-168, 2007.
14. Brechbuhl HM, Kachadourian R, Min E, Chan D and Day BJ: Chrysin enhances doxorubicin-induced cytotoxicity in human lung epithelial cancer cell lines: the role of glutathione. Toxicol Appl Pharmacol 258: 1-9, 2012.
15. Li X, Huang Q, Ong CN, Yang XF and Shen HM: Chrysin sensitizes tumor necrosis factor-alpha-induced apoptosis in human tumor cells via suppression of nuclear factor-kappaB. Cancer Lett 293: 109-116, 2010.
16. Li X, Wang JN, Huang JM, et al: Chrysin promotes tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) induced apoptosis in human cancer cell lines. Toxicol In Vitro 25: 630-635, 2011.
17. Wagner H, Chari VM and Sonnenbichler J: 13C-NMR-spektren natürlich vorkommender flavonoide. Tetrahedron Lett 17: 1799-1802, 1976 (In German).
18. Gaydou EM and Bianchini JP: Études de composés flavoniques I. Synthèses et propriétés (UV, RMN du 13C) de quelques flavones. Bull Soc Chim Fr II: 43-47, 1978.
19. Choo MK, Kawasaki N, Singhirunnusorn P, et al: Blockade of transforming growth factor-beta-activated kinase 1 activity enhances TRAIL-induced apoptosis through activation of a caspase cascade. Mol Cancer Ther 5: 2970-2976, 2006. (Pubitemid 46092038)
20. Lirdprapamongkol K, Kramb JP, Suthiphongchai T, et al: Vanillin suppresses metastatic potential of human cancer cells through PI3K inhibition and decreases angiogenesis in vivo. J Agric Food Chem 57: 3055-3063, 2009.
21. Lirdprapamongkol K, Sakurai H, Suzuki S, et al: Vanillin enhances TRAIL-induced apoptosis in cancer cells through inhibition of NF-kappaB activation. In Vivo 24: 501-506, 2010.
22. Yu C, Bruzek LM, Meng XW, et al: The role of Mcl-1 downregulation in the proapoptotic activity of the multikinase inhibitor BAY 43-9006. Oncogene 24: 6861-6869, 2005. (Pubitemid 41509409)
23. Unger RE, Krump-Konvalinkova V, Peters K and Kirkpatrick CJ: In vitro expression of the endothelial phenotype: comparative study of primary isolated cells and cell lines, including the novel cell line HPMEC-ST1.6R. Microvasc Res 64: 384-397, 2002. (Pubitemid 35370740)
24. Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25: 402-408, 2001. (Pubitemid 34164012)
25. Jung EM, Lim JH, Lee TJ, Park JW, Choi KS and Kwon TK: Curcumin sensitizes tumor necrosis factor-related apoptosis-inducing ligand (TRAIL)-induced apoptosis through reactive oxygen species-mediated upregulation of death receptor 5 (DR5). Carcinogenesis 26: 1905-1913, 2005. (Pubitemid 41631263)
26. Jacquemin G, Shirley S and Micheau O: Combining naturally occurring polyphenols with TNF-related apoptosis-inducing ligand: a promising approach to kill resistant cancer cells? Cell Mol Life Sci 67: 3115-3130, 2010.
27. Bannerman DD, Tupper JC, Ricketts WA, Bennett CF, Winn RK and Harlan JM: A constitutive cytoprotective pathway protects endothelial cells from lipopolysaccharide-induced apoptosis. J Biol Chem 276: 14924-14932, 2001.
28. Akgul C: Mcl-1 is a potential therapeutic target in multiple types of cancer. Cell Mol Life Sci 66: 1326-1336, 2009.
29. Aggarwal BB, Kunnumakkara AB, Harikumar KB, et al: Signal transducer and activator of transcription-3, inflammation, and cancer: how intimate is the relationship? Ann NY Acad Sci 1171: 59-76, 2009.
30. Meng XW, Lee SH, Dai H, et al: Mcl-1 as a buffer for proapoptotic Bcl-2 family members during TRAIL-induced apoptosis: a mechanistic basis for sorafenib (Bay 43-9006)-induced TRAIL sensitization. J Biol Chem 282: 29831-29846, 2007. (Pubitemid 350035287)
31. Hsieh FC, Cheng G and Lin J: Evaluation of potential Stat3-regulated genes in human breast cancer. Biochem Biophys Res Commun 335: 292-299, 2005. (Pubitemid 41140220)
32. Nijhawan D, Fang M, Traer E, et al: Elimination of Mcl-1 is required for the initiation of apoptosis following ultraviolet irradiation. Genes Dev 17: 1475-1486, 2003. (Pubitemid 36734705)
33. Poukkula M, Kaunisto A, Hietakangas V, et al: Rapid turnover of c-FLIPshort is determined by its unique C-terminal tail. J Biol Chem 280: 27345-27355, 2005. (Pubitemid 41040776)
34. Dong Y, Yin S, Li J, Jiang C, Ye M and Hu H: Bufadienolide compounds sensitize human breast cancer cells to TRAIL-induced apoptosis via inhibition of STAT3/Mcl-1 pathway. Apoptosis 16: 394-403, 2011.
35. Huang S and Sinicrope FA: Sorafenib inhibits STAT3 activation to enhance TRAIL-mediated apoptosis in human pancreatic cancer cells. Mol Cancer Ther 9: 742-750, 2010.
36. Chen KF, Tai WT, Liu TH, et al: Sorafenib overcomes TRAIL resistance of hepatocellular carcinoma cells through the inhibition of STAT3. Clin Cancer Res 16: 5189-5199, 2010.
37. Polier G, Ding J, Konkimalla BV, et al: Wogonin and related natural flavones are inhibitors of CDK9 that induce apoptosis in cancer cells by transcriptional suppression of Mcl-1. Cell Death Dis 2: e182, 2011.
38. Phan T, Yu XM, Kunnimalaiyaan M and Chen H: Antiproliferative effect of chrysin on anaplastic thyroid cancer. J Surg Res 170: 84-88, 2011.
39. Wang S and Fischer PM: Cyclin-dependent kinase 9: a key transcriptional regulator and potential drug target in oncology, virology and cardiology. Trends Pharmacol Sci 29: 302-313, 2008.
40. Giraud S, Hurlstone A, Avril S and Coqueret O: Implication of BRG1 and cdk9 in the STAT3-mediated activation of the p21waf1 gene. Oncogene 23: 7391-7398, 2004. (Pubitemid 39382141)
41. Hou T, Ray S and Brasier AR: The functional role of an interleukin 6-inducible CDK9.STAT3 complex in human gamma-fibrinogen gene expression. J Biol Chem 282: 37091-37102, 2007.
42. Fu B, Xue J, Li Z, Shi X, Jiang BH and Fang J: Chrysin inhibits expression of hypoxia-inducible factor-1alpha through reducing hypoxia-inducible factor-1alpha stability and inhibiting its protein synthesis. Mol Cancer Ther 6: 220-226, 2007. (Pubitemid 46206685)
43. Von Brandenstein MG, Ngum Abety A, Depping R, et al: A p38-p65 transcription complex induced by endothelin-1 mediates signal transduction in cancer cells. Biochim Biophys Acta 1783: 1613-1622, 2008.
44. Shao JJ, Zhang AP, Qin W, Zheng L, Zhu YF and Chen X: AMP-activated protein kinase (AMPK) activation is involved in chrysin-induced growth inhibition and apoptosis in cultured A549 lung cancer cells. Biochem Biophys Res Commun 423: 448-453, 2012.